Sungsoo Kim

Title: Innovations of Sungsoo Kim

Introduction

Sungsoo Kim is a notable inventor based in Jinju-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of variants that enhance photosensitivity.

Latest Patents

Sungsoo Kim holds a patent for a CRY2 variant that has increased photosensitivity. This invention involves a CRY2 variant in which E279 and/or E281, which have a negative charge in a NSEGE sequence of SEQ ID NO: 1, is substituted with any one selected from the neutral amino acid group of alanine (A), isoleucine (I), leucine (L), valine (V), phenylalanine (F), methionine (M), and tryptophan (W). Additionally, S278 or G280 of the NSEGE sequence can be substituted with bulky amino acids such as tryptophan (W) and phenylalanine (F). This innovation has the potential to advance various applications in the field.

Career Highlights

Sungsoo Kim is affiliated with the Institute for Basic Science, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to enhancing photosensitivity in biological systems.

Collaborations

Sungsoo Kim collaborates with esteemed colleagues, including Wondo Heo and Sang Kyu Lee. Their combined expertise contributes to the advancement of their research initiatives.

Conclusion

Sungsoo Kim's contributions to biotechnology, particularly through his patented CRY2 variant, highlight his role as an influential inventor in the field. His ongoing work at the Institute for Basic Science promises to yield further innovations in the future.